Targeted application of bridged fragments in the design of physiologically active compoundsстатья
Информация о цитировании статьи получена из
Web of Science
Статья опубликована в журнале из списка Web of Science и/или Scopus
Дата последнего поиска статьи во внешних источниках: 27 мая 2015 г.
Аннотация:The present review comprises the examples of targeted application of bridged groups in drug design for the purposes of bioisosteric replacement, conformational restriction, or enhancement of lipophilicity of the lead-compound and as the scaffolds securing a proper orientation of the binding groups.